Skip to main content
Top
Published in: Surgery Today 9/2013

01-09-2013 | Original Article

Clinical features and management of pouchitis in Japanese ulcerative colitis patients

Authors: Motoi Uchino, Hiroki Ikeuchi, Hiroki Matsuoka, Toshihiro Bando, Yoshio Takesue, Naohiro Tomita

Published in: Surgery Today | Issue 9/2013

Login to get access

Abstract

Purpose

Pouchitis frequently occurs after restorative proctocolectomy for ulcerative colitis. This study evaluated the incidence and treatment of pouchitis in Japanese ulcerative colitis patients.

Method

This study reviewed the clinical data from 772 patients with pouch surgery between January 2000 and December 2010. Pouchitis was classified as acute or chronic pouchitis. The potential preoperative risk factors for overall and chronic pouchitis were analyzed using a logistic regression analysis.

Result

The incidence of overall pouchitis and the cumulative risk of developing overall pouchitis were 10.0 % (77/772) and 10.7 % after 10 years, respectively. In addition, 74.0 % of all patients who developed overall pouchitis did so within 2 years after surgery. Chronic pouchitis occurred in 37.7 %. Although no independent risk factor for overall pouchitis was found, age at the onset of ulcerative colitis <26 years and surgical indications of toxic megacolon were found to be risk factors for chronic pouchitis and surgical indications of cancer/dysplasia were significantly associated with a low risk of overall pouchitis and patients with cancer/dysplasia were older than patients with other surgical indications (p < 0.01).

Conclusion

Immune abnormalities in younger onset patients or toxic megacolon may be more significant than surgical indications of cancer/dysplasia in elderly patients. Fundamental immune abnormalities may remain even after proctocolectomy.
Literature
1.
go back to reference Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK. Ileal pouch-anal anastomosis: complications and function in 1005 patients. Ann Surg. 1995;222:120–7.PubMedCrossRef Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, Schroeder TK. Ileal pouch-anal anastomosis: complications and function in 1005 patients. Ann Surg. 1995;222:120–7.PubMedCrossRef
2.
go back to reference Penna C, Dozois R, Tremaine W, Sandborn W, LaRusso N, Schleck C, Ilstrup D. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut. 1996;38:234–9.PubMedCrossRef Penna C, Dozois R, Tremaine W, Sandborn W, LaRusso N, Schleck C, Ilstrup D. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut. 1996;38:234–9.PubMedCrossRef
3.
go back to reference Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg. 1996;131:497–500.PubMedCrossRef Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg. 1996;131:497–500.PubMedCrossRef
4.
go back to reference Stahlberg D, Gullberg K, Liljeqvist L, Hellers G, Löfberg R. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum. 1996;39:1012–8.PubMedCrossRef Stahlberg D, Gullberg K, Liljeqvist L, Hellers G, Löfberg R. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum. 1996;39:1012–8.PubMedCrossRef
5.
go back to reference de Paiva NM, Ayrizono ML, Milanski M, Coope A, Oliveira LM, Fagundes JJ, Velloso LA, Coy CS, Leal RF. Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients? Int J Clin Exp Med. 2011;4:179–86.PubMed de Paiva NM, Ayrizono ML, Milanski M, Coope A, Oliveira LM, Fagundes JJ, Velloso LA, Coy CS, Leal RF. Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients? Int J Clin Exp Med. 2011;4:179–86.PubMed
6.
go back to reference Okita Y, Miki C, Yoshiyama S, Otake K, Araki T, Uchida K, Kusunoki M. Neutrophil dysfunction in steroid-overdosed patients with ulcerative colitis: potential relevance of macrophage migration inhibitory factor to increased postoperative morbidity. Surg Today. 2011;41:1504–11.PubMedCrossRef Okita Y, Miki C, Yoshiyama S, Otake K, Araki T, Uchida K, Kusunoki M. Neutrophil dysfunction in steroid-overdosed patients with ulcerative colitis: potential relevance of macrophage migration inhibitory factor to increased postoperative morbidity. Surg Today. 2011;41:1504–11.PubMedCrossRef
7.
go back to reference Ikeuchi H, Nakano H, Uchino M, Nakamura M, Yanagi H, Noda M, Yamamura T. Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients. Dig Surg. 2004;21:197–201.PubMedCrossRef Ikeuchi H, Nakano H, Uchino M, Nakamura M, Yanagi H, Noda M, Yamamura T. Incidence and therapeutic outcome of pouchitis for ulcerative colitis in Japanese patients. Dig Surg. 2004;21:197–201.PubMedCrossRef
8.
go back to reference Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc. 1994;69:409–15.PubMedCrossRef Sandborn WJ, Tremaine WJ, Batts KP, Pemberton JH, Phillips SF. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc. 1994;69:409–15.PubMedCrossRef
9.
go back to reference Sandborn WJ. Pouchitis: risk factors, frequency, natural history, classification and public health prospective. In: McLeod RS, Martin F, Sutherland LR, Wallace JL, Williams CN, editors. Trends in Inflammatory Bowel Disease 1996. Lancaster: Kluwer; 1997. p. 51–63. Sandborn WJ. Pouchitis: risk factors, frequency, natural history, classification and public health prospective. In: McLeod RS, Martin F, Sutherland LR, Wallace JL, Williams CN, editors. Trends in Inflammatory Bowel Disease 1996. Lancaster: Kluwer; 1997. p. 51–63.
10.
go back to reference Shen B. Diagnosis and management of patients with pouchitis. Drugs. 2003;65:453–61.CrossRef Shen B. Diagnosis and management of patients with pouchitis. Drugs. 2003;65:453–61.CrossRef
11.
go back to reference Heuschen UA, Allemeyer EH, Hinz U, Autschbach F, Uehlein T, Herfarth C, Heuschen G. Diagnosing pouchitis: comparative validation of two scoring system in routine follow-up. Dis Colon Rectum. 2002;45:776–86.PubMedCrossRef Heuschen UA, Allemeyer EH, Hinz U, Autschbach F, Uehlein T, Herfarth C, Heuschen G. Diagnosing pouchitis: comparative validation of two scoring system in routine follow-up. Dis Colon Rectum. 2002;45:776–86.PubMedCrossRef
12.
go back to reference Truelove SC, Witts LF. Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ. 1995;2:1041–8.CrossRef Truelove SC, Witts LF. Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ. 1995;2:1041–8.CrossRef
14.
go back to reference Mahadadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology. 2003;124:1636–50.CrossRef Mahadadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology. 2003;124:1636–50.CrossRef
15.
go back to reference Lipman JM, Kiran RP, Shen B, Remzi F, Fazio VW. Perioperative factors during ileal pouch-anal anastomosis predict pouchitis. Dis Colon Rectum. 2011;54:311–7.PubMedCrossRef Lipman JM, Kiran RP, Shen B, Remzi F, Fazio VW. Perioperative factors during ileal pouch-anal anastomosis predict pouchitis. Dis Colon Rectum. 2011;54:311–7.PubMedCrossRef
16.
go back to reference Yantiss RK, Sapp HL, Farraye FA, El-Zammar O, O’Brien MJ, Fruin AB, Stucchi AF, Brien TP, Becker JM, Odze RD. Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol. 2004;28:999–1006.PubMedCrossRef Yantiss RK, Sapp HL, Farraye FA, El-Zammar O, O’Brien MJ, Fruin AB, Stucchi AF, Brien TP, Becker JM, Odze RD. Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol. 2004;28:999–1006.PubMedCrossRef
17.
go back to reference Suzuki H, Ogawa H, Shibata C, Haneda S, Watanabe K, Takahashi K, Funayama Y, Sasaki I. The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. Dis Colon Rectum. 2012;55:330–6.PubMedCrossRef Suzuki H, Ogawa H, Shibata C, Haneda S, Watanabe K, Takahashi K, Funayama Y, Sasaki I. The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. Dis Colon Rectum. 2012;55:330–6.PubMedCrossRef
18.
go back to reference Shen B, Achkar JP, Lashner BA, Ormsby AH, Brzezinski A, Soffer EE, Remzi FH, Bevins CL, Fazio VW. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol. 2002;97:972–7.PubMedCrossRef Shen B, Achkar JP, Lashner BA, Ormsby AH, Brzezinski A, Soffer EE, Remzi FH, Bevins CL, Fazio VW. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol. 2002;97:972–7.PubMedCrossRef
19.
go back to reference Kohyama M, Takesue Y, Ohge H, Murakami Y, Shimamoto F, Sueda T. Pouchitis disease activity index (PDAI) does not predict patients with symptoms of pouchitis who will respond to antibiotics. Surg Today. 2009;39:962–8.PubMedCrossRef Kohyama M, Takesue Y, Ohge H, Murakami Y, Shimamoto F, Sueda T. Pouchitis disease activity index (PDAI) does not predict patients with symptoms of pouchitis who will respond to antibiotics. Surg Today. 2009;39:962–8.PubMedCrossRef
21.
go back to reference Shen B, Achkar JP, Lashner BA, Ormsby AH, Remzi FH, Brzezinski A, Bevins CL, Bambrick ML, Seidner DL, Fazio VW. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis. 2001;7:301–5.PubMedCrossRef Shen B, Achkar JP, Lashner BA, Ormsby AH, Remzi FH, Brzezinski A, Bevins CL, Bambrick ML, Seidner DL, Fazio VW. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis. Inflamm Bowel Dis. 2001;7:301–5.PubMedCrossRef
22.
go back to reference Pardi DS, D’Haens G, Shen B, Campbell S, Gionchetti P. Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis. 2009;15:1424–31.PubMedCrossRef Pardi DS, D’Haens G, Shen B, Campbell S, Gionchetti P. Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis. 2009;15:1424–31.PubMedCrossRef
23.
go back to reference Navaneethan U, Shen B. Pros and cons of antibiotic therapy for pouchitis. Expert Rev Gastroenterol Hepatol. 2009;3:547–59.PubMedCrossRef Navaneethan U, Shen B. Pros and cons of antibiotic therapy for pouchitis. Expert Rev Gastroenterol Hepatol. 2009;3:547–59.PubMedCrossRef
24.
go back to reference Winter TA, Dalton HR, Merrett MN, Campbell A, Jewell DP. Cyclosporin A retention enemas in refractory pouchitis and ileitis. Scand J Gastroenterol. 1993;28:701–4.PubMedCrossRef Winter TA, Dalton HR, Merrett MN, Campbell A, Jewell DP. Cyclosporin A retention enemas in refractory pouchitis and ileitis. Scand J Gastroenterol. 1993;28:701–4.PubMedCrossRef
25.
go back to reference Hait EJ, Bousvaros A, Schuman M, Shamberger RC, Lillehei CW. Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery. J Pediatr Surg. 2007;42:31–34; discussion 34–35. Hait EJ, Bousvaros A, Schuman M, Shamberger RC, Lillehei CW. Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery. J Pediatr Surg. 2007;42:31–34; discussion 34–35.
26.
go back to reference Calabrese C, Gionchetti P, Rizzello F, Liguori G, Gabusi V, Tambasco R, Poggioli G, Pierangeli F, Campieri M, Di Febo G. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther. 2008;27:759–64.PubMedCrossRef Calabrese C, Gionchetti P, Rizzello F, Liguori G, Gabusi V, Tambasco R, Poggioli G, Pierangeli F, Campieri M, Di Febo G. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. Aliment Pharmacol Ther. 2008;27:759–64.PubMedCrossRef
27.
go back to reference Viscido A, Habib FI, Kohn A, Papi C, Marcheggiano A, Pimpo MT, Vernia P, Cadau G, Caprilli R. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther. 2003;17:126312–71.CrossRef Viscido A, Habib FI, Kohn A, Papi C, Marcheggiano A, Pimpo MT, Vernia P, Cadau G, Caprilli R. Infliximab in refractory pouchitis complicated by fistulae following ileo-anal pouch for ulcerative colitis. Aliment Pharmacol Ther. 2003;17:126312–71.CrossRef
Metadata
Title
Clinical features and management of pouchitis in Japanese ulcerative colitis patients
Authors
Motoi Uchino
Hiroki Ikeuchi
Hiroki Matsuoka
Toshihiro Bando
Yoshio Takesue
Naohiro Tomita
Publication date
01-09-2013
Publisher
Springer Japan
Published in
Surgery Today / Issue 9/2013
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-012-0377-4

Other articles of this Issue 9/2013

Surgery Today 9/2013 Go to the issue